Curaleaf Holdings Inc. - Asset Resilience Ratio
Curaleaf Holdings Inc. (CURA) has an Asset Resilience Ratio of 3.73% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Curaleaf Holdings Inc. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2024)
This chart shows how Curaleaf Holdings Inc.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see total assets of Curaleaf Holdings Inc..
Liquid Assets Composition Over Time
This chart breaks down Curaleaf Holdings Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Curaleaf Holdings Inc. (CURA) financial obligations for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$107.49 Million | 3.73% |
| Short-term Investments | CA$0.00 | 0% |
| Total Liquid Assets | CA$107.49 Million | 3.73% |
Asset Resilience Insights
- Limited Liquidity: Curaleaf Holdings Inc. maintains only 3.73% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Curaleaf Holdings Inc. Industry Peers by Asset Resilience Ratio
Compare Curaleaf Holdings Inc.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Yunnan Baiyao Group Co Ltd
SHE:000538 |
Drug Manufacturers - Specialty & Generic | 8.38% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Harbin Gloria Pharmaceuticals
SHE:002437 |
Drug Manufacturers - Specialty & Generic | 9.04% |
|
Jiuzhitang Co Ltd
SHE:000989 |
Drug Manufacturers - Specialty & Generic | 7.86% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
Annual Asset Resilience Ratio for Curaleaf Holdings Inc. (2022–2024)
The table below shows the annual Asset Resilience Ratio data for Curaleaf Holdings Inc..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 3.64% | CA$107.23 Million ≈ $77.57 Million |
CA$2.95 Billion ≈ $2.13 Billion |
+0.66pp |
| 2023-12-31 | 2.98% | CA$92.29 Million ≈ $66.76 Million |
CA$3.10 Billion ≈ $2.24 Billion |
-1.80pp |
| 2022-12-31 | 4.78% | CA$163.18 Million ≈ $118.04 Million |
CA$3.41 Billion ≈ $2.47 Billion |
-- |
About Curaleaf Holdings Inc.
Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as distillate droppers, mints, topical balms and lotions, tinct… Read more